… the efficacies of artemisinin-based combination therapies during a 10-year period of deployment
as first-line antimalarials in Nigeria, we report a significant decline of early responses of …

… of artemisinin-based combination treatments (ACTs) and … ACTs are still largely efficacious
treatments of uncomplicated … However, report of declining responsiveness in P. falciparum …

… early treatment response markers 10 years after the adoption of ACTs as first-line treatments
… Methods: At 14 sentinel sites in six geographical areas of Nigeria, we evaluated treatment …

… and being used in combination with chemotherapy. However, … series of hyaluronidase-responsive
size-reducible biomimetic … A and ROS-responsive paclitaxel dimer prodrug (PXTK) are …

… This provided support for using combination treatments to … treatment and declined thereafter
[29]. The exception was IFN-γ, which peaked after 3 weeks of treatment before declining. …

… It is, however, in contradistinction to the reports of declining responsiveness of P. falciparum
to ACTs in Kenya or Suriname [53, 54] or resistance to artemisinin in the Greater Mekong …

… , declining responsiveness to artemether–lumefantrine (AL), the artemisinin-based combination
therapy … [25] recently reported a decline in the responsiveness of childhood P. falciparum …

… treatment in responders among PCa patients remain unclear. The observed correlation
between declining MDSCs and clinical responsiveness … potential benefit of combining WBM with …

… as a measure of responsiveness to antimalarial drugs. … the relationship that may indicate
declining responsiveness in P. … Parasite multiplication and declines after antimalarial treatments …

… the treatment responsiveness in patients with ASUC. … The primary end point was response
to treatment (decline in the … immune suppression in the combination treatment arm, the risk of …